Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DPPA3 pseudogene 9 (DPPA3P9) is an annotated, non-functional genomic segment similar in sequence to the *DPPA3* gene. Pseudogenes arise from functional genes but accumulate mutations that prevent them from encoding a functional protein. The canonical *DPPA3* gene (Developmental pluripotency associated 3) is involved in epigenetic regulation and early embryonic development, but DPPA3P9 itself does not encode a protein and is not considered a therapeutic target. Most pseudogenes like DPPA3P9 do not have roles as receptors, enzymes, or direct disease drivers, though some pseudogenes in general can regulate related genes through RNA-based mechanisms[1][3][5]. There is no evidence that DPPA3P9 has any such regulatory function or clinical relevance. DPPA3P9 is a pseudogene, not a receptor, protein, or tractable therapeutic target; any confusion may result from conflating it with the functional *DPPA3* gene, which is biologically active and relevant to epigenetic regulation and stem cell biology[1][4][2].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DPPA3 pseudogene 9 (DPPA3P9).